Retraction: Shamim et al. Nonsurgical Reduction of the Interventricular Septum in Patients with Hypertrophic Cardiomyopathy. N Engl J Med 2002;347:1326-33.
To the editor: On October 24, 2002, an article about septalablation with alcohol for hypertrophic cardiomyopathy was publishedin the Journal.1 The majority of those named as authors of thearticle did not have an opportunity to review and verify thedata and to approve the manuscript. This unfortunate situationcame to light when the article was published. In view of thisirregularity in the submission process, we request that thatpaper be retracted. We believe that the alcohol-ablation techniquedescribed is a useful procedure in selected patients with hypertrophiccardiomyopathy, and other data support this view.2,3 We alsowant to make clear that the Cleveland Clinic Foundation wasnot involved in the study but was mentioned purely as an addressfor correspondence. We hope that readers of the Journal willunderstand that this retraction is designed to maintain theintegrity of the scientific process.
Andrew J.S. Coats, M.D. Michael Henein, Ph.D. Marcus Flather, F.R.C.P. Ulrich Sigwart, M.D. Hubert Seggewiss, M.D. DuolaoWang, Ph.D. Mohammed Yousufuddin, M.D. Waqar Shamim, M.D.
References
Shamim W, Yousufuddin M, Wang D, et al. Nonsurgical reduction of the interventricular septum in patients with hypertrophic cardiomyopathy. N Engl J Med 2002;347:1326-1333. [Free Full Text]
Faber L, Meissner A, Ziemessen P, Seggewiss H. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients. Heart 2000;83:326-331. [Free Full Text]
Mazur W, Nagueh SF, Lakkis NM, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 2001;103:1492-1496. [Free Full Text]